New Research from Burke Neurological Institute Suggests Raising Vitamin B1 Levels May Provide Novel Treatment for Alzheimer’s Disease
The research was published in the Journal of Alzheimer's Disease and paves the way for a larger clinical trial.
- The research was published in the Journal of Alzheimer's Disease and paves the way for a larger clinical trial.
- Half of the group of 70 participants took 300-mg benfotiamine pills twice daily, while the other half took placebo (inert) pills.
- The complete clinical trial and research were published in the November 2020 issue of Journal of Alzheimers Disease.
- The Burke Neurological Institute is based in White Plains, NY, and was established in 1978 by Dr. Fletcher McDowell as a research institute dedicated to finding cures for chronic neurological disabilities.